Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 24,524 | 20,034 | 18,927 | 16,323 | 15,878 |
| Operating Income | -24,524 | -20,034 | -18,927 | -16,323 | -15,878 |
| Interest Expense | 370 | 349 | 310 | 272 | 254 |
| Other Income | 2,695 | 2,202 | 1,390 | 408 | 108 |
| Pre-tax Income | -22,199 | -18,181 | -17,847 | -16,187 | -16,024 |
| Net Income Continuous | -22,199 | -18,181 | -17,847 | -16,187 | -16,024 |
| Net Income | $-22,199 | $-18,181 | $-17,847 | $-16,187 | $-16,024 |
| EPS Basic Total Ops | -3.10 | -2.53 | -2.50 | -2.50 | -2.60 |
| EPS Basic Continuous Ops | -3.07 | -2.49 | -2.47 | -2.52 | -2.64 |
| EPS Diluted Total Ops | -3.10 | -2.53 | -2.50 | -2.50 | -2.60 |
| EPS Diluted Continuous Ops | -3.07 | -2.49 | -2.47 | -2.52 | -2.64 |
| EBITDA(a) | $-25,919 | $-21,619 | $-19,041 | $-15,599 | $-15,069 |